Andelyn Biosciences, Inc.

Andelyn Biosciences is a gene therapy-focused CDMO providing development and manufacturing services from concept through commercialization. Its capabilities include viral vector and plasmid manufacturing, process development, laboratory services, technology transfer, and the AAV Curator® Platform for program-specific optimization. The company reports experience supporting rare-disease programs, more than 500 cGMP clinical batches, and operations across two specialized facilities.